Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-25-002511
Filing Date
2025-05-21
Accepted
2025-05-21 16:49:27
Documents
1
Period of Report
2025-05-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6899
  Complete submission text file 0000902664-25-002511.txt   8948
Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200, PMB 1237 SAN JUAN PR 00901-1607
Business Address
Nichols Weston (Reporting) CIK: 0001746376 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40603 | Film No.: 25973724

Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607
Business Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 703-963-7214
Lynx1 Capital Management LP (Reporting) CIK: 0001910456 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40603 | Film No.: 25973725